Novartispharma.com - Novartis

Provided by Alexa ranking, novartispharma.com has ranked N/A in N/A and 4,591,081 on the world. novartispharma.com reaches roughly 674 users per day and delivers about 20,218 users each month. The domain novartispharma.com uses a Commercial suffix and it's server(s) are located in N/A with the IP number 45.60.13.232 and it is a .com domain.

WebNovartis. Reimagining medicine together. Working together, we can reimagine medicine to improve and extend people’s lives. My Cancer. My Words. In a world where about half of … novartis.com novartis.com novartis.com novartis.com novartis.com novartis.com

List of domain same IP 45.60.13.232

Keywords on this domain

Search Results related to novartispharma.com on Search Engine

Novartis
novartis.com

https://www.novartis.com/

WebNovartis. Reimagining medicine together. Working together, we can reimagine medicine to improve and extend people’s lives. My Cancer. My Words. In a world where about half of … novartis.com novartis.com novartis.com novartis.com novartis.com novartis.com

novartis.com

DA: 33 PA: 67 MOZ Rank: 84

Novartis United States of America
novartis.com

https://www.novartis.com/us-en/

WebApr 6, 2024 · Contact Us. Find information on our research locations and corporate offices in US. Careers. 769 million lives touched by our products. Join us. View more. Novartis …

DA: 4 PA: 66 MOZ Rank: 76

Novartis - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Novartis

OverviewHistoryCorporate structurePlace in its market segmentsResearchProductsControversies and criticismPhilanthropyNovartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to Founded: March 1996; 27 years ago, (from merger) Number of employees: 101,703 (2022)

Founded: March 1996; 27 years ago, (from merger)
Number of employees: 101,703 (2022)

DA: 81 PA: 20 MOZ Rank: 32

Novartis announces new organizational structure to
globenewswire.com

https://www.globenewswire.com/news-release/2022/04/04/2415244/0/en/Novartis-announces-new-organizational-structure-to-accelerate-growth-strengthen-pipeline-and-increase-productivity.html

WebApril 04, 2022 01:00 ET | Source: Novartis Pharma AG. Follow. Ad hoc announcement pursuant to Art. 53 LR. New simplified structure and operational set-up supports Novartis …

DA: 57 PA: 8 MOZ Rank: 83

Novartis announces new organizational structure to - GlobeNewswire
globenewswire.com

https://www.globenewswire.com/news-release/2022/04/04/2415244/0/en/Novartis-announces-new-organizational-structure-to-accelerate-growth-strengthen-pipeline-and-increase-productivity.html

DA: 50 PA: 7 MOZ Rank: 62

Novartis unveils new focused strategy, underpinned by eight …
yahoo.com

https://finance.yahoo.com/news/novartis-unveils-focused-strategy-underpinned-051500211.html

WebSep 22, 2022 · Novartis Pharma AG. Transformation to pure-play Innovative Medicines company nears completion. Focusing strategy on five core Therapeutic Areas, key …

DA: 31 PA: 74 MOZ Rank: 11

Novartis unveils new focused strategy, underpinned by eight
globenewswire.com

https://www.globenewswire.com/news-release/2022/09/22/2520690/0/en/Novartis-unveils-new-focused-strategy-underpinned-by-eight-potential-multi-billion-dollar-peak-sales-brands-deep-pipeline-at-Meet-the-Management-event.html

WebSeptember 22, 2022 01:15 ET | Source: Novartis Pharma AG. Follow. Transformation to pure-play Innovative Medicines company nears completion. Focusing strategy on five …

DA: 57 PA: 89 MOZ Rank: 26

Novartis - YouTube
youtube.com

https://www.youtube.com/user/Novartis

WebNovartis is an innovative medicines company. Every day, we working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are...

DA: 19 PA: 73 MOZ Rank: 96

Novartis to prioritise U.S. market, unfazed by drug pricing pushback
reuters.com

https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-unveils-new-strategy-based-eight-multi-billion-dollar-brands-2022-09-22/

WebZURICH, Sept 22 (Reuters) - Swiss pharma giant Novartis (NOVN.S) said it would make growth in the United States its top geographic priority, even after laws were passed to …

DA: 2 PA: 11 MOZ Rank: 36

Patient Savings Co-Pay Card | Novartis Pharmaceuticals
novartispharma.com

https://www.copay.novartispharma.com/nvscopay/

WebAt Novartis Pharmaceuticals Corporation, we know that access to your medication is important. That's why we created a prescription co-pay savings program that's simple to …

DA: 2 PA: 100 MOZ Rank: 7

Alexa Rank

GLOBAL RANK

4,591,081

Alexa Reach

0.0000297504

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

674

Monthly Unique Visitors

20,218

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

4,325

Indonesia

3,383

Taiwan

1,100

United Kingdom

977

Brazil

884

Nigeria

772

Egypt

649

Hong Kong

613

Canada

613

Australia

534

Philippines

382

India

372

Malaysia

366

Spain

303

Germany

295

Mexico

283

France

267

Italy

247

Turkey

226

Iraq

206

Thailand

202

Netherlands

194

Israel

192

Cambodia

160

Algeria

123

Ireland

111

Romania

107

Jordan

Poland

Ghana

Argentina

South Africa

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa Statistics Graph for novartispharma.com

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

100

MOZ Rank

Semcrush Traffic Graph

Semrush Statistics Graph for novartispharma.com

DNS Record

Host	Type	Class	TTL	Extra
novartispharma.com	A	IN	21600	Ip: 45.60.13.232
novartispharma.com	A	IN	21600	Ip: 45.60.11.232
novartispharma.com	NS	IN	1800	Target: a24-65.akam.net
novartispharma.com	NS	IN	1800	Target: dns3.novartis.com
novartispharma.com	NS	IN	1800	Target: a2-66.akam.net
novartispharma.com	NS	IN	1800	Target: a7-64.akam.net
novartispharma.com	NS	IN	1800	Target: a28-67.akam.net
novartispharma.com	NS	IN	1800	Target: dns1.novartis.com
novartispharma.com	NS	IN	1800	Target: a1-254.akam.net
novartispharma.com	NS	IN	1800	Target: dns4.novartis.com
novartispharma.com	NS	IN	1800	Target: a9-65.akam.net
novartispharma.com	NS	IN	1800	Target: dns2.novartis.com
novartispharma.com	SOA	IN	21600	Mname: dns1.novartis.com Rname: hostmaster.novartis.com Serial: 2023092701 Refresh: 28800 Retry: 7200 Expire: 604800 Minimum-ttl: 3600
novartispharma.com	TXT	IN	21600	Txt: hfz0qt9c1q6yyt1r92j0lc8hcs2jlhzd Entries_0: hfz0qt9c1q6yyt1r92j0lc8hcs2jlhzd
novartispharma.com	TXT	IN	21600	Txt: xncncncmp877zyv08v7ymwntmy28959q Entries_0: xncncncmp877zyv08v7ymwntmy28959q
novartispharma.com	TXT	IN	21600	Txt: _globalsign-domain-verification=7sds8V_yxJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna Entries_0: _globalsign-domain-verification=7sds8V_yxJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna
novartispharma.com	TXT	IN	21600	Txt: globalsign-domain-verification=9DC80CC1EF5047759E837E1536E2F538 Entries_0: globalsign-domain-verification=9DC80CC1EF5047759E837E1536E2F538
novartispharma.com	TXT	IN	21600	Txt: QuoVadis=8c5c8859-79dc-463e-a1cb-372bd00b49ba Entries_0: QuoVadis=8c5c8859-79dc-463e-a1cb-372bd00b49ba
novartispharma.com	TXT	IN	21600	Txt: globalsign-domain-verification=af383c045070b328e5f0baf90466d137 Entries_0: globalsign-domain-verification=af383c045070b328e5f0baf90466d137
novartispharma.com	TXT	IN	21600	Txt: 7cdd5904eb31493b86849e2bf3213f6d Entries_0: 7cdd5904eb31493b86849e2bf3213f6d
novartispharma.com	TXT	IN	21600	Txt: globalsign-domain-verification=68a0803dd1b30525e5b39671e41205e6 Entries_0: globalsign-domain-verification=68a0803dd1b30525e5b39671e41205e6
novartispharma.com	TXT	IN	21600	Txt: globalsign-domain-verification=0d907e851dee01b2cf16eee6871d5ad4 Entries_0: globalsign-domain-verification=0d907e851dee01b2cf16eee6871d5ad4
novartispharma.com	TXT	IN	21600	Txt: QuoVadis=6b92f675-13b5-460f-90b0-76a449cdeffa Entries_0: QuoVadis=6b92f675-13b5-460f-90b0-76a449cdeffa

Hosting and Whois Zone

IP	45.60.13.232
Domain infomation	Domain Name: NOVARTISPHARMA.COM Registry Domain ID: 11748121_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2022-09-25T09:03:18Z Creation Date: 1999-10-27T12:09:24Z Registry Expiry Date: 2024-10-27T12:09:24Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of whois database: 2024-04-18T06:00:17Z <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars.